Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Safety of protease inhibitors in HIV-infected pregnant women.

Chougrani I, Luton D, Matheron S, Mandelbrot L, Azria E.

HIV AIDS (Auckl). 2013 Sep 27;5:253-62. doi: 10.2147/HIV.S33058. eCollection 2013. Review.

PMID:
24101883
[PubMed]
Free PMC Article
2.

Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?

Thorne C, Newell ML.

Drug Saf. 2007;30(3):203-13. Review.

PMID:
17343429
[PubMed - indexed for MEDLINE]
3.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
[PubMed - indexed for MEDLINE]
4.

HIV protease inhibitors in pregnancy : pharmacology and clinical use.

Andany N, Loutfy MR.

Drugs. 2013 Mar;73(3):229-47. doi: 10.1007/s40265-013-0017-3. Review.

PMID:
23404092
[PubMed - indexed for MEDLINE]
5.

U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.

Mofenson LM; Centers for Disease Control and Prevention, U.S. Public Health Service Task Force.

MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4.

PMID:
12489844
[PubMed - indexed for MEDLINE]
Free Article
6.

Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.

Senise JF, Castelo A, Martínez M.

AIDS Rev. 2011 Oct-Dec;13(4):198-213. Review.

PMID:
21975356
[PubMed - indexed for MEDLINE]
7.

Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.

[No authors listed]

MMWR Recomm Rep. 1998 Jan 30;47(RR-2):1-30. Erratum in: MMWR Morb Mortal Wkly Rep 1998 Apr 24;47(15):315. MMWR Morb Mortal Wkly Rep 1998 Apr 17;47(14):287.

PMID:
9461044
[PubMed - indexed for MEDLINE]
Free Article
8.

The safety of antiretroviral drugs in pregnancy.

Thorne C, Newell ML.

Expert Opin Drug Saf. 2005 Mar;4(2):323-35. Review.

PMID:
15794723
[PubMed - indexed for MEDLINE]
9.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
[PubMed - indexed for MEDLINE]
10.

Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study.

Lorenzi P, Spicher VM, Laubereau B, Hirschel B, Kind C, Rudin C, Irion O, Kaiser L.

AIDS. 1998 Dec 24;12(18):F241-7.

PMID:
9875571
[PubMed - indexed for MEDLINE]
11.

Treating HIV during pregnancy: an update on safety issues.

Watts DH.

Drug Saf. 2006;29(6):467-90. Review.

PMID:
16752931
[PubMed - indexed for MEDLINE]
12.

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Review.

PMID:
21735394
[PubMed - indexed for MEDLINE]
13.

Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.

[No authors listed]

Prescrire Int. 2004 Aug;13(72):144-50.

PMID:
15532140
[PubMed - indexed for MEDLINE]
14.

Protease inhibitor-based antiretroviral prophylaxis during pregnancy and the development of drug resistance.

Gingelmaier A, Eberle J, Kost BP, Bogner JR, Hofmann J, Weissenbacher T, Kästner R, Friese K, Weizsaecker K.

Clin Infect Dis. 2010 Mar 15;50(6):890-4. doi: 10.1086/650747.

PMID:
20166821
[PubMed - indexed for MEDLINE]
Free Article
15.

Antiretroviral therapy in pregnancy: a focus on safety.

Taylor GP, Low-Beer N.

Drug Saf. 2001;24(9):683-702. Review.

PMID:
11522121
[PubMed - indexed for MEDLINE]
16.

Clinical pharmacology of HIV protease inhibitors in pregnancy.

van der Lugt J, Colbers A, Burger D.

Curr Opin HIV AIDS. 2008 Nov;3(6):620-6. doi: 10.1097/COH.0b013e3283136cc5.

PMID:
19373033
[PubMed]
17.

[HIV infection, antiretroviral therapy, and endothelium].

Hürlimann D, Weber R, Enseleit F, Lüscher TF.

Herz. 2005 Sep;30(6):472-80. Review. German.

PMID:
16170677
[PubMed - indexed for MEDLINE]
18.

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, O'Sullivan MJ, Scott G, Stek AM, Wara D, Bulterys M.

N Engl J Med. 2002 Jun 13;346(24):1863-70.

PMID:
12063370
[PubMed - indexed for MEDLINE]
Free Article
19.

Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV.

Lee LM, Henderson DK.

Drug Saf. 2001;24(8):587-97. Review.

PMID:
11480491
[PubMed - indexed for MEDLINE]
20.

Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery.

Gingelmaier A, Kurowski M, Kästner R, Eberle J, Mylonas I, Belohradsky BH, Friese K, Grubert TA.

AIDS. 2006 Aug 22;20(13):1737-43.

PMID:
16931938
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk